Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 109, Issue 45, Pages E3119-E3127
Publisher
Proceedings of the National Academy of Sciences
Online
2012-10-16
DOI
10.1073/pnas.1216078109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P4-17-01: Trastuzumab Does Not Increase the Incidence of Central Nervous System (CNS) Relapses in HER2−Positive Early Breast Cancer: The HERA Trial Experience.
- (2012) B Pestalozzi et al. CANCER RESEARCH
- HER2011: The Changing Face of HER2-Positive Breast Cancer
- (2012) George W. Sledge Clinical Breast Cancer
- Analysis of Fc Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients
- (2012) S. A. Hurvitz et al. CLINICAL CANCER RESEARCH
- Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
- (2012) Valentina Guarneri et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study
- (2012) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Bevacizumab in Combination with Trastuzumab and Capecitabine as First-Line Treatment for HER-2-positive Locally Recurrent or Metastatic Breast Cancer
- (2012) M. Martin et al. ONCOLOGIST
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER
- (2011) A. M. Brufsky et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
- (2011) J. T. Garrett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2
- (2010) Xiao-Feng Le et al. CELL CYCLE
- Preclinical approaches to study the biology and treatment of brain metastases
- (2010) William Cruz-Muñoz et al. SEMINARS IN CANCER BIOLOGY
- The role of the organ microenvironment in brain metastasis
- (2010) Isaiah J. Fidler SEMINARS IN CANCER BIOLOGY
- Bevacizumab Safety in Patients with Central Nervous System Metastases
- (2009) B. Besse et al. CLINICAL CANCER RESEARCH
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
- (2009) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Central Nervous System Metastases
- (2009) Brian Leyland-Jones JOURNAL OF CLINICAL ONCOLOGY
- Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2009) Neil L. Spector et al. JOURNAL OF CLINICAL ONCOLOGY
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- Real-time imaging reveals the single steps of brain metastasis formation
- (2009) Yvonne Kienast et al. NATURE MEDICINE
- Secreted Gaussia Luciferase as a Biomarker for Monitoring Tumor Progression and Treatment Response of Systemic Metastases
- (2009) Euiheon Chung et al. PLoS One
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- A secreted luciferase for ex vivo monitoring of in vivo processes
- (2008) Thomas Wurdinger et al. NATURE METHODS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started